We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+10.95%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$629M
AUM Growth
+$97.2M
Cap. Flow
+$42.9M
Cap. Flow %
6.82%
Top 10 Hldgs %
65.36%
Holding
29
New
3
Increased
8
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$18.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$18.3M
3
ABT icon
Abbott
ABT
+$14.8M
4
LH icon
Labcorp
LH
+$11.6M
5
ELV icon
Elevance Health
ELV
+$10.1M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$16.7M
2
EXEL icon
Exelixis
EXEL
+$7.75M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$5.93M
4
UTHR icon
United Therapeutics
UTHR
+$5.91M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.89M

Sector Composition

Rank Sector Weight
1 Healthcare 98.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
1
Abbott
ABT
$175B
$58.6M 9.31%
1,318,642
+342,052
+35% +$14.8M
LLY icon
2
Eli Lilly
LLY
$1.05T
$55.6M 8.85%
661,350
-5,700
-0.9% -$457K
BAX icon
3
Baxter International
BAX
$11.7B
$53.7M 8.55%
1,036,233
+83,400
+9% +$4.1M
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$42.5M 6.77%
782,390
+333,100
+74% +$18.3M
RVTY icon
5
Revvity
RVTY
$12.3B
$36.2M 5.76%
623,408
– –
BSX icon
6
Boston Scientific
BSX
$65.4B
$35.4M 5.63%
1,423,880
+168,300
+13% +$4.09M
ELV icon
7
Elevance Health
ELV
$80.9B
$33.8M 5.38%
204,610
+63,800
+45% +$10.1M
IRWD icon
8
Ironwood Pharmaceuticals
IRWD
$635M
$33.1M 5.27%
2,317,289
-38,089
-2% -$521K
SHPG
9
DELISTED
Shire pic
SHPG
$31.5M 5.01%
180,761
+33,800
+23% +$5.9M
GILD icon
10
Gilead Sciences
GILD
$167B
$30.5M 4.84%
448,490
+89,200
+25% +$6.27M
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$123B
$29.2M 4.64%
267,050
-66,900
-20% -$5.89M
MASI
12
DELISTED
Masimo
MASI
$24.1M 3.83%
258,218
-54,786
-18% -$4.51M
BIO icon
13
Bio-Rad Laboratories Class A
BIO
$8.15B
$22.7M 3.62%
114,042
– –
IART icon
14
Integra LifeSciences
IART
$1.5B
$20.6M 3.27%
488,230
-74,184
-13% -$3.17M
PDCO
15
DELISTED
Patterson Companies, Inc.
PDCO
$17.5M 2.78%
386,232
– –
MCK icon
16
McKesson
MCK
$98.5B
$17.1M 2.72%
115,200
– –
PRGO icon
17
Perrigo
PRGO
$1.48B
$16.4M 2.61%
+247,340
New +$18.8M
CI icon
18
Cigna
CI
$74.5B
$12.3M 1.96%
84,270
-11,000
-12% -$1.62M
LH icon
19
Labcorp
LH
$23.2B
$12M 1.91%
+97,660
New +$11.6M
LPNT
20
DELISTED
LifePoint Health, Inc.
LPNT
$10.8M 1.72%
164,714
– –
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$10.1M 1.61%
756,765
-98,500
-12% -$1.54M
IPXL
22
DELISTED
Impax Laboratories, Inc.
IPXL
$6.76M 1.08%
534,311
+35,158
+7% +$425K
ACH
23
Accendra Health
ACH
$266M
$5.05M 0.8%
145,874
-68,298
-32% -$2.44M
LXRX icon
24
Lexicon Pharmaceuticals
LXRX
$1.06B
$4.76M 0.76%
+332,300
New +$4.93M
THC icon
25
Tenet Healthcare
THC
$16.8B
$4.46M 0.71%
252,080
– –
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2017 Portfolio in Review

As of Q1 2017, Sector Gamma AS held 29 positions worth $629M, up 18% from $532M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sector Gamma AS deployed $42.9M of net new capital in Q1 2017, opening 3 new positions and adding to 8 existing holdings. Its largest new stake was Perrigo: 247,340 shares worth $16.4M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

On the sell side, the largest reduction was United Therapeutics, an estimated $5.91M trimmed.

  • Sector Gamma AS's largest Q1 2017 buy was Perrigo: 247,340 shares worth $16.4M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q1 2017, an estimated $18.3M increase.
  • Sector Gamma AS's biggest Q1 2017 reduction was United Therapeutics, cutting an estimated $5.91M.
  • Sector Gamma AS fully exited Merck in Q1 2017, selling an estimated $16.7M.
  • Sector Gamma AS's ten largest holdings make up 65% of its $629M portfolio in Q1 2017.
  • Sector Gamma AS opened 3 new positions and closed 3 in Q1 2017.
  • Sector Gamma AS's portfolio value rose 18% quarter-over-quarter to $629M.

Based on Sector Gamma AS's 13F filing for Q1 2017, filed 12 May 2017.